Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 8;10(1):84.
doi: 10.1038/s41540-024-00407-8.

Modelling HIV-1 control and remission

Affiliations
Review

Modelling HIV-1 control and remission

Bharadwaj Vemparala et al. NPJ Syst Biol Appl. .

Abstract

Remarkable advances are being made in developing interventions for eliciting long-term remission of HIV-1 infection. The success of these interventions will obviate the need for lifelong antiretroviral therapy, the current standard-of-care, and benefit the millions living today with HIV-1. Mathematical modelling has made significant contributions to these efforts. It has helped elucidate the possible mechanistic origins of natural and post-treatment control, deduced potential pathways of the loss of such control, quantified the effects of interventions, and developed frameworks for their rational optimization. Yet, several important questions remain, posing challenges to the translation of these promising interventions. Here, we survey the recent advances in the mathematical modelling of HIV-1 control and remission, highlight their contributions, and discuss potential avenues for future developments.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Outcomes of HIV-1 infection and ART.
a The population prevalence of the three different outcomes, viz., chronic progressors (CP, magenta), natural controllers (NC, yellow) and post-treatment controllers (PTC, cyan),. b, c Cartoons showing viral load trajectories in the different scenarios.
Fig. 2
Fig. 2. HIV-1 infection dynamics.
a A schematic of the within-host model encoded in Eqs. (1)–(5) (see text). b Numerical simulation of the model in (a). We let f1=λdTT and f2=dLL. Parameter values used,: λ = 104 cells/mL-d, β = 10−5.5 mL/copies-d, ε = 0.99, dT = 0.01 /d, ϕD = 0.93, ϕL = 10−6, a = 10−3/d, dI = 1.0/d, dD = 0.07/d, dL = 0.004/d, p = 2000 copies/cells-d and dV = 23/d. Initiation conditions: T(0)=λ/dT, V(0) = 10−2 copies/mL and no infected cells. The dashed line is the limit of detection of viral RNA (1 copy/mL) using ultrasensitive assays.
Fig. 3
Fig. 3. Adaptive immune responses to HIV-1 infection.
Responses mediated by (a) CD8 T cells (red) and (b) antibodies (green), considered in within-host mathematical models. Exhaustion (black blunted line in (a)) is also considered in models.
Fig. 4
Fig. 4. Viral evolution and immune escape.
Schematic showing mutation and recombination creating diverse viral genomes (middle), facilitating the selection of variants that escape antibody (left) and CD8 T cell (right) mediated immune pressures. While antibody escape mutations typically enable virus particles to resist clearance and other antibody-mediated immune functions, CD8 T cell escape mutations prevent the infected cell from being identified by CD8 T cells and thus limit their effector responses.

Similar articles

Cited by

References

    1. Bekker, L. G. et al. HIV infection. Nat. Rev. Dis. Prim.9, 42, 10.1038/s41572-023-00452-3 (2023). 10.1038/s41572-023-00452-3 - DOI - PubMed
    1. Deeks, S. G. et al. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021. Nat. Med.27, 2085–2098, 10.1038/s41591-021-01590-5 (2021). 10.1038/s41591-021-01590-5 - DOI - PubMed
    1. Deeks, S. G. & Walker, B. D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity27, 406–416, 10.1016/j.immuni.2007.08.010 (2007). 10.1016/j.immuni.2007.08.010 - DOI - PubMed
    1. Saez-Cirion, A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLoS Pathog.9, e1003211, 10.1371/journal.ppat.1003211 (2013). 10.1371/journal.ppat.1003211 - DOI - PMC - PubMed
    1. Li, J. Z. & Blankson, J. N. How elite controllers and posttreatment controllers inform our search for an HIV-1 cure. J. Clin. Invest.131, e149414, 10.1172/JCI149414 (2021). 10.1172/JCI149414 - DOI - PMC - PubMed

Substances

LinkOut - more resources